NCT05263947 2026-02-24
Bevacizumab Combined With Double Doses of Icotinib in Advanced NSCLC Patients With EGFR L858R Mutation
Tianjin Medical University Cancer Institute and Hospital
Phase 2 Completed
Tianjin Medical University Cancer Institute and Hospital
Sun Yat-sen University
Beijing Tiantan Hospital
Tianjin Medical University Cancer Institute and Hospital
Fuda Cancer Hospital, Guangzhou
Taizhou Hospital
Guangdong Association of Clinical Trials
Zhejiang Cancer Hospital